Compare ALEMBIC LTD with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TORRENT PHARMA - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD TORRENT PHARMA ALEMBIC LTD/
TORRENT PHARMA
 
P/E (TTM) x 67.3 59.0 114.2% View Chart
P/BV x 2.4 6.2 38.3% View Chart
Dividend Yield % 0.4 0.8 51.9%  

Financials

 ALEMBIC LTD   TORRENT PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
TORRENT PHARMA
Mar-18
ALEMBIC LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs721,550 4.6%   
Low Rs341,144 3.0%   
Sales per share (Unadj.) Rs4.7354.7 1.3%  
Earnings per share (Unadj.) Rs6.140.1 15.2%  
Cash flow per share (Unadj.) Rs6.264.2 9.7%  
Dividends per share (Unadj.) Rs0.2014.00 1.4%  
Dividend yield (eoy) %0.41.0 36.3%  
Book value per share (Unadj.) Rs40.7273.1 14.9%  
Shares outstanding (eoy) m267.03169.22 157.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.8 296.7%   
Avg P/E ratio x8.733.6 25.8%  
P/CF ratio (eoy) x8.521.0 40.4%  
Price / Book Value ratio x1.34.9 26.4%  
Dividend payout %3.334.9 9.4%   
Avg Mkt Cap Rs m14,139227,897 6.2%   
No. of employees `000NA14.7 0.0%   
Total wages/salary Rs m20711,353 1.8%   
Avg. sales/employee Rs ThNM4,083.0-  
Avg. wages/employee Rs ThNM772.3-  
Avg. net profit/employee Rs ThNM461.3-  
INCOME DATA
Net Sales Rs m1,25560,021 2.1%  
Other income Rs m3702,988 12.4%   
Total revenues Rs m1,62563,009 2.6%   
Gross profit Rs m11113,493 0.8%  
Depreciation Rs m384,086 0.9%   
Interest Rs m23,085 0.1%   
Profit before tax Rs m4429,310 4.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,529 0.9%   
Profit after tax Rs m1,6306,781 24.0%  
Gross profit margin %8.922.5 39.4%  
Effective tax rate %5.427.2 20.0%   
Net profit margin %129.811.3 1,149.3%  
BALANCE SHEET DATA
Current assets Rs m1,86752,623 3.5%   
Current liabilities Rs m59152,022 1.1%   
Net working cap to sales %101.61.0 10,143.1%  
Current ratio x3.21.0 312.2%  
Inventory Days Days94120 78.8%  
Debtors Days Days7476 96.5%  
Net fixed assets Rs m1,79185,016 2.1%   
Share capital Rs m534846 63.1%   
"Free" reserves Rs m10,32445,376 22.8%   
Net worth Rs m10,85846,222 23.5%   
Long term debt Rs m4141,115 0.1%   
Total assets Rs m11,591142,432 8.1%  
Interest coverage x260.94.0 6,492.8%   
Debt to equity ratio x00.9 0.4%  
Sales to assets ratio x0.10.4 25.7%   
Return on assets %14.16.9 203.2%  
Return on equity %15.014.7 102.3%  
Return on capital %15.214.2 107.0%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1914,580 0.1%   
Fx outflow Rs m2643,600 7.3%   
Net fx Rs m-24410,980 -2.2%   
CASH FLOW
From Operations Rs m2368,942 2.6%  
From Investments Rs m-224-47,070 0.5%  
From Financial Activity Rs m-2734,174 -0.1%  
Net Cashflow Rs m-15-3,655 0.4%  

Share Holding

Indian Promoters % 64.0 71.5 89.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 7.0 2.8%  
FIIs % 9.7 12.6 77.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 8.8 296.6%  
Shareholders   54,701 26,511 206.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   UNICHEM LAB  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 292 Points Higher; Automobile and Metal Stocks Witness Buying(Closing)

After opening the day marginally higher, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Oct 15, 2019 03:37 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS